Bio-Techne Corp
Company Profile
Business description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Contact
614 McKinley Place N.E.
MinneapolisMN55413
USAT: +1 612 379-8854
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2027
Employees
3,000
Stocks News & Analysis
stocks
Apple earnings: A smooth transition despite continued memory and supply headwinds
stocks
Two new ASX names added to our Global Best Stock Ideas
stocks
Big four bank holds up in weakening economic conditions
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,937.30 | 71.60 | -0.79% |
| CAC 40 | 8,020.31 | 27.38 | -0.34% |
| DAX 40 | 25,864.62 | 116.47 | -0.45% |
| Dow JONES (US) | 51,786.72 | 197.26 | -0.38% |
| FTSE 100 | 10,638.43 | 122.90 | -1.14% |
| HKSE | 23,472.27 | 53.70 | -0.23% |
| NASDAQ | 25,372.01 | 207.65 | 0.83% |
| Nikkei 225 | 60,835.36 | 2,246.50 | -3.56% |
| NZX 50 Index | 13,771.31 | 51.05 | 0.37% |
| S&P 500 | 7,568.92 | 27.52 | 0.36% |
| S&P/ASX 200 | 8,816.80 | 70.00 | -0.79% |
| SSE Composite Index | 3,597.47 | 10.63 | -0.29% |